Related Experiment Videos
Ara-C metabolism: implications for drug resistance and drug interactions
Abstract:
Clinical studies of resistance to cytosine arabinoside have not produced agreement as to the specific biochemical lesions responsible for altered sensitivity, although experimental and clinical work supports the concept that a decreased ability to generate ara-CTP must be the ultimate effect of this lesion. 3-deazauridine, an inhibitor of CTP synthetase, was found to enhance ara-CTP production in murine tumor cells, and in the present study, was shown to inhibit deamination of ara-C at both the nucleoside and nucleotide level. Enhanced ara-CTP formation was observed in cells lacking cytidine deaminase (L1 210 and HL60), indicating that 3-deazauridine inhibition of deoxycytidylate deaminase may be important in this drug interaction.
Insights
This study reveals that 3-deazauridine enhances the anti-cancer drug cytosine arabinoside (ara-C) efficacy by inhibiting its deamination. This leads to increased production of the active metabolite, ara-CTP, in tumor cells.
Area of Science:
- Biochemistry
- Pharmacology
- Cancer Research
Background:
- Clinical resistance to cytosine arabinoside (ara-C) lacks consensus on biochemical causes.
- Decreased generation of the active metabolite, ara-CTP, is a suspected mechanism for ara-C resistance.
- Cytidine deaminase plays a role in ara-C metabolism.
Purpose of the Study:
- To investigate the mechanism by which 3-deazauridine affects cytosine arabinoside (ara-C) metabolism.
- To determine if 3-deazauridine can overcome resistance to ara-C by enhancing ara-CTP production.
- To explore the role of cytidine deaminase in this drug interaction.
Main Methods:
- Treatment of murine tumor cells with 3-deazauridine and cytosine arabinoside (ara-C).
- Measurement of ara-CTP production and ara-C deamination.
- Analysis of drug effects in cell lines with varying levels of cytidine deaminase activity.
Main Results:
- 3-deazauridine enhanced ara-CTP production in murine tumor cells.
- 3-deazauridine inhibited the deamination of ara-C at both nucleoside and nucleotide levels.
- Enhanced ara-CTP formation was observed in cells lacking cytidine deaminase.
Conclusions:
- 3-deazauridine can enhance the efficacy of cytosine arabinoside (ara-C) by inhibiting its deamination.
- The inhibition of deoxycytidylate deaminase by 3-deazauridine may be a key factor in this drug interaction.
- Targeting cytidine deaminase could be a strategy to improve ara-C therapy.